SCHEMBL13289559

SCHEMBL13289559

Bc1cnn2c(NCCNC(=O)Nc3cc(Cl)ccc3OC)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ HTR3E A5X5Y0 1/20 0.45
▸ HTR3B O95264 1/20 0.45
▸ HTR3A P46098 1/20 0.45
▸ HTR3D Q70Z44 1/20 0.45
▸ HTR3C Q8WXA8 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MEN1 O00255 7/20 0.42
▸ KMT2A Q03164 7/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GSK3B P49841 2/20 0.41
▸ IGF1R P08069 2/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ RBP4 P02753 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13289360 0.95 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2C19HTR3EHTR3B
SCHEMBL13121921 0.91 GSK3B (0.53) ALDH1A1CYP1A2CYP2C19HTR3EHTR3B
SCHEMBL13289584 0.87 MEN1 (0.44) ALDH1A1CYP2C19MEN1KMT2ATP53
SCHEMBL13121840 0.87 GSK3B (0.51) ALDH1A1CYP1A2CYP2C19HTR3EHTR3B
SCHEMBL13289615 0.85 GSK3B (0.45) CYP1A2CYP2C19MEN1KMT2ATP53
SCHEMBL13121885 0.85 GSK3B (0.56) ALDH1A1HTR3EHTR3BHTR3AHTR3D
SCHEMBL14545834 0.84 GSK3B (0.44) ALDH1A1MEN1KMT2AGSK3BCDK2
SCHEMBL13289322 0.83 GSK3B (0.46) ALDH1A1KMT2AMAPTGSK3BCDK2
SCHEMBL13121640 0.82 CDK2 (0.61) ALDH1A1CYP1A2CYP2C19MEN1KMT2A
SCHEMBL13289349 0.81 GSK3B (0.46) ALDH1A1CYP1A2CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback